CXC chemokines and chemokine receptors in gastric cancer: From basic findings towards therapeutic targeting

World Journal of Gastroenterology

Volumn 20, Issue 7, 2014, Pages 1681-1693

  Lee, Hyo Jin ^a,b   Song, Ik Chan ^a   Yun, Hwan Jung ^a,b   Jo, Deog Yeon ^a,b   Kim, Samyong ^a,b  

^a Chungnam National University College of Medicine   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Chemokine; Chemokine receptor; Gastric neoplasm; Therapeutic target

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE RECEPTOR CXCR; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR6; CHEMOKINE RECEPTOR CXCR7; CXCL16 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; G PROTEIN COUPLED RECEPTOR; GELATINASE A; GELATINASE B; INTERLEUKIN 8; MAMMALIAN TARGET OF RAPAMYCIN; MATRILYSIN; PHOSPHATIDYLINOSITOL 3 KINASE; STROMAL CELL DERIVED FACTOR 1; CHEMOKINE RECEPTOR;

ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CARCINOGENESIS; HUMAN; IMMUNE RESPONSE; METASTASIS; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR INVASION; TUMOR MICROENVIRONMENT; CARCINOMA; CELL SURVIVAL; CELL TRANSFORMATION; DISEASE COURSE; METABOLISM; PATHOLOGY; PROGNOSIS; QUALITY OF LIFE; STOMACH; STOMACH NEOPLASMS; TREATMENT OUTCOME;

CARCINOMA; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINES, CXC; DISEASE PROGRESSION; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; QUALITY OF LIFE; RECEPTORS, CHEMOKINE; STOMACH; STOMACH NEOPLASMS; TREATMENT OUTCOME; TUMOR MICROENVIRONMENT;

EID: 84894285024     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i7.1681     Document Type: Article

References (160)

1. Thiel A, Ristimäki A. Gastric cancer: basic aspects. Helicobacter 2012; 17 Suppl 1: 26-29 [PMID: 22958152 DOI: 10.1111/ j.1523-5378.2012.00979.x]
2. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29 [PMID: 10449602]
3. Lee HJ, Cho do Y, Park JC, Bae SB, Lee KT, Cho IS, Han CS, Park SY, Yun HJ, Kim S. Phase II trial of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin in patients with advanced or recurrent inoperable gastric cancer. Cancer Chemother Pharmacol 2009; 63: 427-432 [PMID: 18415100 DOI: 10.1007/s00280-008-0752-4]
4. Zheng L, Wang L, Ajani J, Xie K. Molecular basis of gastric cancer development and progression. Gastric Cancer 2004; 7: 61-77 [PMID: 15224192 DOI: 10.1007/s10120-004-0277-4]
5. Lee HJ, Jo DY. The role of the CXCR4/CXCL12 axis and its clinical implications in gastric cancer. Histol Histopathol 2012; 27: 1155-1161 [PMID: 22806902]
6. Ebert MP, Fei G, Kahmann S, Müller O, Yu J, Sung JJ, Malfertheiner P. Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 2002; 23: 87-91 [PMID: 11756228]
7. Panani AD. Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett 2008; 266: 99-115 [PMID: 18381231 DOI: 10.1016/j.canlet.2008.02.053]
8. Resende C, Ristimäki A, Machado JC. Genetic and epigenetic alteration in gastric carcinogenesis. Helicobacter 2010; 15 Suppl 1: 34-39 [PMID: 21054651 DOI: 10.1111/ j.1523-5378.2010.00782.x]
9. Oda N, Tsujino T, Tsuda T, Yoshida K, Nakayama H, Yasui W, Tahara E. DNA ploidy pattern and amplification of ERBB and ERBB2 genes in human gastric carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol 1990; 58: 273-277 [PMID: 1970690]
10. Ross JS, McKenna BJ. The HER-2/neu oncogene in tumors of the gastrointestinal tract. Cancer Invest 2001; 19: 554-568 [PMID: 11458821]
11. Shun CT, Wu MS, Lin JT, Chen SY, Wang HP, Lee WJ, Wang TH, Chuang SM. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer. Hepatogastroenterology 1997; 44: 604-609 [PMID: 9164544]
12. Han S, Kim HY, Park K, Cho HJ, Lee MS, Kim HJ, Kim YD. c-Myc expression is related with cell proliferation and associated with poor clinical outcome in human gastric cancer. J Korean Med Sci 1999; 14: 526-530 [PMID: 10576148]
13. Kozma L, Kiss I, Hajdú J, Szentkereszty Z, Szakáll S, Ember I. C-myc amplification and cluster analysis in human gastric carcinoma. Anticancer Res 2001; 21: 707-710 [PMID: 11299830]
14. Pan G, Lv H, Ren H, Wang Y, Liu Y, Jiang H, Wen J. Elevated expression of semaphorin 5A in human gastric cancer and its implication in carcinogenesis. Life Sci 2010; 86: 139-144 [PMID: 20026339 DOI: 10.1016/j.lfs.2009.12.004]
15. Florou D, Papadopoulos IN, Scorilas A. Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer. Biochem Biophys Res Commun 2010; 391: 214-218 [PMID: 19903463 DOI: 10.1016/j.bbrc.2009.11.034]
16. Kuniyasu H, Yasui W, Yokozaki H, Kitadai Y, Tahara E. Aberrant expression of c-met mRNA in human gastric carcinomas. Int J Cancer 1993; 55: 72-75 [PMID: 8344755]
17. Hattori Y, Odagiri H, Nakatani H, Miyagawa K, Naito K, Sakamoto H, Katoh O, Yoshida T, Sugimura T, Terada M. K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc Natl Acad Sci USA 1990; 87: 5983-5987 [PMID: 2377625]
18. Liu XP, Tsushimi K, Tsushimi M, Oga A, Kawauchi S, Furuya T, Sasaki K. Expression of p53 protein as a prognostic indicator of reduced survival time in diffuse-type gastric carcinoma. Pathol Int 2001; 51: 440-444 [PMID: 11422805]
19. Nakatsuru S, Yanagisawa A, Ichii S, Tahara E, Kato Y, Nakamura Y, Horii A. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet 1992; 1: 559-563 [PMID: 1338691]
20. Lee KH, Lee JS, Suh C, Kim SW, Kim SB, Lee JH, Lee MS, Park MY, Sun HS, Kim SH. Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases. Cancer 1995; 75: 2794-2801 [PMID: 7773929]
21. More H, Humar B, Weber W, Ward R, Christian A, Lintott C, Graziano F, Ruzzo AM, Acosta E, Boman B, Harlan M, Ferreira P, Seruca R, Suriano G, Guilford P. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene. Hum Mutat 2007; 28: 203 [PMID: 17221870 DOI: 10.1002/humu.9473]
22. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Rüschoff J, Kang YK. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, openlabel, randomised controlled trial. Lancet 2010; 376: 687-697 [PMID: 20728210 DOI: 10.1016/s0140-6736(10)61121-x]
23. Balkwill FR. The chemokine system and cancer. J Pathol 2012; 226: 148-157 [PMID: 21989643 DOI: 10.1002/path.3029]
24. Koizumi K, Hojo S, Akashi T, Yasumoto K, Saiki I. Chemokine receptors in cancer metastasis and cancer cellderived chemokines in host immune response. Cancer Sci 2007; 98: 1652-1658 [PMID: 17894551 DOI: 10.1111/ j.1349-7006.2007.00606.x]
25. Burger JA. Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): from understanding the basics towards therapeutic targeting. Semin Cancer Biol 2010; 20: 424-430 [PMID: 20883788 DOI: 10.1016/ j.semcancer.2010.09.005]
26. Kunkel SL, Strieter RM, Lindley IJ, Westwick J. Chemokines: new ligands, receptors and activities. Immunol Today 1995; 16: 559-561 [PMID: 8579746 DOI: 10.1016/0167-5699(95)80076-x]
27. Keeley EC, Mehrad B, Strieter RM. CXC chemokines in cancer angiogenesis and metastases. Adv Cancer Res 2010; 106: 91-111 [PMID: 20399957 DOI: 10.1016/s0065-230x(10)06003-3]
28. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354: 610-621 [PMID: 16467548 DOI: 10.1056/NEJMra052723]
29. Vicari AP, Caux C. Chemokines in cancer. Cytokine Growth Factor Rev 2002; 13: 143-154 [PMID: 11900990]
30. Vandercappellen J, Van Damme J, Struyf S. The role of CXC chemokines and their receptors in cancer. Cancer Lett 2008; 267: 226-244 [PMID: 18579287 DOI: 10.1016/ j.canlet.2008.04.050]
31. Zhu Q, Han X, Peng J, Qin H, Wang Y. The role of CXC chemokines and their receptors in the progression and treatment of tumors. J Mol Histol 2012; 43: 699-713 [PMID: 22752457. DOI: 10.1007/s10735-012-9435-x]
32. Verbeke H, Struyf S, Laureys G, Van Damme J. The expression and role of CXC chemokines in colorectal cancer. Cytokine Growth Factor Rev 2011; 22: 345-358 [PMID: 22000992 DOI: 10.1016/j.cytogfr.2011.09.002]
33. Strieter RM, Burdick MD, Mestas J, Gomperts B, Keane MP, Belperio JA. Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 2006; 42: 768-778 [PMID: 16510280 DOI: 10.1016/j.ejca.2006.01.006]
34. Rainczuk A, Rao J, Gathercole J, Stephens AN. The emerging role of CXC chemokines in epithelial ovarian cancer. Reproduction 2012; 144: 303-317 [PMID: 22771929 DOI: 10.1530/ rep-12-0153]
35. Fernandez EJ, Lolis E. Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 2002; 42: 469-499 [PMID: 11807180 DOI: 10.1146/annurev.pharmtox. 42.091901.115838]
36. Arya M, Patel HR, Williamson M. Chemokines: key players in cancer. Curr Med Res Opin 2003; 19: 557-564 [PMID: 14594528. DOI: 10.1185/030079903125002216]
37. Verbeke H, Geboes K, Van Damme J, Struyf S. The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer. Biochim Biophys Acta 2012; 1825: 117-129 [PMID: 22079531 DOI: 10.1016/ j.bbcan.2011.10.008]
38. Luster AD. Chemokines--chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436-445 [PMID: 9459648. DOI: 10.1056/nejm199802123380706]
39. Tazzyman S, Lewis CE, Murdoch C. Neutrophils: key mediators of tumour angiogenesis. Int J Exp Pathol 2009; 90: 222-231 [PMID: 19563607 DOI: 10.1111/j.1365-2613.2009.00641.x]
40. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D. The functional role of the ELR motif in CXC chemokinemediated angiogenesis. J Biol Chem 1995; 270: 27348-27357 [PMID: 7592998]
41. Strieter RM, Burdick MD, Gomperts BN, Belperio JA, Keane MP. CXC chemokines in angiogenesis. Cytokine Growth Factor Rev 2005; 16: 593-609 [PMID: 16046180 DOI: 10.1016/ j.cytogfr.2005.04.007]
42. Strieter RM, Belperio JA, Phillips RJ, Keane MP. CXC chemokines in angiogenesis of cancer. Semin Cancer Biol 2004; 14: 195-200 [PMID: 15246055 DOI: 10.1016/ j.semcancer.2003.10.006]
43. Zipin-Roitman A, Meshel T, Sagi-Assif O, Shalmon B, Avivi C, Pfeffer RM, Witz IP, Ben-Baruch A. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res 2007; 67: 3396-3405 [PMID: 17409450 DOI: 10.1158/0008-5472.can-06-3087]
44. Kawada K, Sonoshita M, Sakashita H, Takabayashi A, Yamaoka Y, Manabe T, Inaba K, Minato N, Oshima M, Taketo MM. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res 2004; 64: 4010-4017 [PMID: 15173015. DOI: 10.1158/0008-5472.can-03-1757]
45. Lee HJ, Kim SW, Kim HY, Li S, Yun HJ, Song KS, Kim S, Jo DY. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer. Int J Oncol 2009; 34: 473-480 [PMID: 19148483]
46. Li S, Huang S, Peng SB. Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression. Int J Oncol 2005; 27: 1329-1339 [PMID: 16211229]
47. Yasumoto K, Koizumi K, Kawashima A, Saitoh Y, Arita Y, Shinohara K, Minami T, Nakayama T, Sakurai H, Takahashi Y, Yoshie O, Saiki I. Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res 2006; 66: 2181-2187 [PMID: 16489019 DOI: 10.1158/0008-5472. can-05-3393]
48. Zhao BC, Zhao B, Han JG, Ma HC, Wang ZJ. Adiposederived stem cells promote gastric cancer cell growth, migration and invasion through SDF-1/CXCR4 axis. Hepatogastroenterology 2010; 57: 1382-1389 [PMID: 21443090]
49. Mitra P, Shibuta K, Mathai J, Shimoda K, Banner BF, Mori M, Barnard GF. CXCR4 mRNA expression in colon, esophageal and gastric cancers and hepatitis C infected liver. Int J Oncol 1999; 14: 917-925 [PMID: 10200342]
50. Zhao BC, Wang ZJ, Mao WZ, Ma HC, Han JG, Zhao B, Xu HM. CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. World J Gastroenterol 2011; 17: 2389-2396 [PMID: 21633638 DOI: 10.3748/wjg.v17.i19.2389]
51. Ingold B, Simon E, Ungethüm U, Kuban RJ, Müller BM, Lupp A, Neumann U, Ebert MP, Denkert C, Weichert W, Schulz S, Röcken C. Vascular CXCR4 expression-a novel antiangiogenic target in gastric cancer? PLoS One 2010; 5: e10087 [PMID: 20386750 DOI: 10.1371/journal. pone.0010087]
52. Pituch-Noworolska A, Drabik G, Szatanek R, Białas M, Kołodziejczyk P, Szczepanik A, Stachura J, Zembala M. Immunophenotype of isolated tumour cells in the blood, bone marrow and lymph nodes of patients with gastric cancer. Pol J Pathol 2007; 58: 93-97 [PMID: 17715675]
53. Yasumoto K, Yamada T, Kawashima A, Wang W, Li Q, Donev IS, Tacheuchi S, Mouri H, Yamashita K, Ohtsubo K, Yano S. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer. Clin Cancer Res 2011; 17: 3619-3630 [PMID: 21482691 DOI: 10.1158/1078-0432. ccr-10-2475]
54. Ying J, Xu Q, Zhang G, Liu B, Zhu L. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis. Med Oncol 2012; 29: 1716-1722 [PMID: 21630055. DOI: 10.1007/s12032-011-9990-0]
55. Zhao C, Ma H, Bu X, Wang W, Zhang N. SFRP5 inhibits gastric epithelial cell migration induced by macrophage-derived Wnt5a. Carcinogenesis 2013; 34: 146-152 [PMID: 23054609 DOI: 10.1093/carcin/bgs309]
56. Xue Z, Yan H, Li J, Liang S, Cai X, Chen X, Wu Q, Gao L, Wu K, Nie Y, Fan D. Identification of cancer stem cells in vincristine preconditioned SGC7901 gastric cancer cell line. J Cell Biochem 2012; 113: 302-312 [PMID: 21913215 DOI: 10.1002/ jcb.23356]
57. Graziosi L, Mencarelli A, Santorelli C, Renga B, Cipriani S, Cavazzoni E, Palladino G, Laufer S, Burnet M, Donini A, Fiorucci S. Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis. Eur J Pharmacol 2012; 674: 143-152 [PMID: 22119383 DOI: 10.1016/ j.ejphar.2011.11.015]
58. Fanelli MF, Chinen LT, Begnami MD, Costa WL, Fregnami JH, Soares FA, Montagnini AL. The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer. Histopathology 2012; 61: 153-161 [PMID: 22582975 DOI: 10.1111/j.1365-2559.2011.04139.x]
59. Kwak MK, Hur K, Park DJ, Lee HJ, Lee HS, Kim WH, Lee KU, Choe KJ, Yang HK. Expression of chemokine receptors in human gastric cancer. Tumour Biol 2005; 26: 65-70 [PMID: 15867478. DOI: 10.1159/000085587]
60. Sun XJ, Sun KL, Zheng ZH, Fu WN, Hao DM, Xu HM, Li XM. Gene expression patterns in gastric cancer. Zhonghua Yixue Yichuanxue Zazhi 2006; 23: 142-146 [PMID: 16604482]
61. Graziosi L, Mencarelli A, Renga B, Santorelli C, Cantarella F, Bugiantella W, Cavazzoni E, Donini A, Fiorucci S. Gene expression changes induced by HIPEC in a murine model of gastric cancer. In Vivo 2012; 26: 39-45 [PMID: 22210714]
62. Xu W, Zhou H, Qian H, Bu X, Chen D, Gu H, Zhu W, Yan Y, Mao F. Combination of circulating CXCR4 and Bmi-1 mRNA in plasma: A potential novel tumor marker for gastric cancer. Mol Med Rep 2012; 2: 765-771 [PMID: 21475899 DOI: 10.3892/ mmr_00000170]
63. Ding YL, Zhang JL, Tang SF, Fu QY, Li ZT. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer]. Zhonghua Yixue Zazhi 2008; 88: 202-205 [PMID: 18361822]
64. Hashimoto I, Koizumi K, Tatematsu M, Minami T, Cho S, Takeno N, Nakashima A, Sakurai H, Saito S, Tsukada K, Saiki I. Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells. Eur J Cancer 2008; 44: 1022-1029 [PMID: 18375114 DOI: 10.1016/ j.ejca.2008.02.043]
65. Zieker D, Königsrainer I, Traub F, Nieselt K, Knapp B, Schillinger C, Stirnkorb C, Fend F, Northoff H, Kupka S, Brücher BL, Königsrainer A. PGK1 a potential marker for peritoneal dissemination in gastric cancer. Cell Physiol Biochem 2008; 21: 429-436 [PMID: 18453750 DOI: 10.1159/000129635]
66. Tsuboi K, Kodera Y, Nakanishi H, Ito S, Mochizuki Y, Nakayama G, Koike M, Fujiwara M, Yamamura Y, Nakao A. Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis. Oncol Rep 2008; 20: 1117-1123 [PMID: 18949410]
67. Arigami T, Natsugoe S, Uenosono Y, Yanagita S, Arima H, Hirata M, Ishigami S, Aikou T. CCR7 and CXCR4 expression predicts lymph node status including micrometastasis in gastric cancer. Int J Oncol 2009; 35: 19-24 [PMID: 19513547]
68. Iwasa S, Yanagawa T, Fan J, Katoh R. Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis. Anticancer Res 2009; 29: 4751-4758 [PMID: 20032431]
69. Zhu S, Hong J, Tripathi MK, Sehdev V, Belkhiri A, El-Rifai W. Regulation of CXCR4-mediated invasion by DARPP-32 in gastric cancer cells. Mol Cancer Res 2013; 11: 86-94 [PMID: 23160836. DOI: 10.1158/1541-7786.mcr-12-0243-t]
70. Bao W, Fu HJ, Xie QS, Wang L, Zhang R, Guo ZY, Zhao J, Meng YL, Ren XL, Wang T, Li Q, Jin BQ, Yao LB, Wang RA, Fan DM, Chen SY, Jia LT, Yang AG. HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells. Gastroenterology 2011; 141: 2076-2087. e6 [PMID: 21925125 DOI: 10.1053/ j.gastro.2011.08.050]
71. He H, Wang C, Shen Z, Fang Y, Wang X, Chen W, Liu F, Qin X, Sun Y. Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer. PLoS One 2013; 8: e71864 [PMID: 23936528. DOI: 10.1371/journal.pone.0071864]
72. Ishigami S, Natsugoe S, Okumura H, Matsumoto M, Nakajo A, Uenosono Y, Arigami T, Uchikado Y, Setoyama T, Arima H, Hokita S, Aikou T. Clinical implication of CXCL12 expression in gastric cancer. Ann Surg Oncol 2007; 14: 3154-3158 [PMID: 17653799 DOI: 10.1245/s10434-007-9521-6]
73. Lee HJ, Huang SM, Kim HY, Oh YS, Hwang JY, Liang ZL, Ki Min J, Yun HJ, Sul JY, Kim S, Jo DY, Kim JM. Evaluation of the combined expression of chemokine SDF-1α and its receptor CXCR4 as a prognostic marker for gastric cancer. Exp Ther Med 2011; 2: 499-504 [PMID: 22977531 DOI: 10.3892/ etm.2011.228]
74. Chen G, Chen SM, Wang X, Ding XF, Ding J, Meng LH. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells. J Biol Chem 2012; 287: 12132-12141 [PMID: 22337890 DOI: 10.1074/ jbc.M111.302299]
75. Song IC, Liang ZL, Lee JC, Huang SM, Kim HY, Oh YS, Yun HJ, Sul JY, Jo DY, Kim S, Kim JM, Lee HJ. Expression of stromal cell-derived factor-1α is an independent risk factor for lymph node metastasis in early gastric cancer. Oncol Lett 2011; 2: 1197-1202 [PMID: 22848288 DOI: 10.3892/ ol.2011.389]
76. Zhi Y, Chen J, Zhang S, Chang X, Ma J, Dai D. Downregulation of CXCL12 by DNA hypermethylation and its involvement in gastric cancer metastatic progression. Dig Dis Sci 2012; 57: 650-659 [PMID: 21960286 DOI: 10.1007/ s10620-011-1922-5]
77. Ruan J, Song H, Li C, Bao C, Fu H, Wang K, Ni J, Cui D. DiR-labeled Embryonic Stem Cells for Targeted Imaging of in vivo Gastric Cancer Cells. Theranostics 2012; 2: 618-628 [PMID: 22768029 DOI: 10.7150/thno.4561]
78. Yanagie H, Hisa T, Ono M, Eriguchi M. [Chemokine and chemokine receptor related to cancer metastasis]. Gan To Kagaku Ryoho 2010; 37: 2052-2057 [PMID: 21084802]
79. Ruan J, Ji J, Song H, Qian Q, Wang K, Wang C, Cui D. Fluorescent magnetic nanoparticle-labeled mesenchymal stem cells for targeted imaging and hyperthermia therapy of in vivo gastric cancer. Nanoscale Res Lett 2012; 7: 309 [PMID: 22709686. DOI: 10.1186/1556-276x-7-309]
80. Schimanski CC, Jordan M, Schlaegel F, Schmidtmann I, Lang H, Galle PR, Moehler M, Gockel I. SNP rs1801157 significantly correlates with distant metastasis in CXCL12 expressing esophagogastric cancer. Int J Oncol 2011; 39: 515-520 [PMID: 21584490 DOI: 10.3892/ijo.2011.1044]
81. Woo IS, Hong SH, Byun JH, Kang JH, Jeon HM, Choi MG. Circulating stromal cell derived factor-1alpha (SDF-1alpha) is predictive of distant metastasis in gastric carcinoma. Cancer Invest 2008; 26: 256-261 [PMID: 18317966 DOI: 10.1080/07 357900701684057]
82. Rempel SA, Dudas S, Ge S, Gutiérrez JA. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 2000; 6: 102-111 [PMID: 10656438]
83. Barbieri F, Bajetto A, Stumm R, Pattarozzi A, Porcile C, Zona G, Dorcaratto A, Ravetti JL, Minuto F, Spaziante R, Schettini G, Ferone D, Florio T. Overexpression of stromal cellderived factor 1 and its receptor CXCR4 induces autocrine/ paracrine cell proliferation in human pituitary adenomas. Clin Cancer Res 2008; 14: 5022-5032 [PMID: 18698020 DOI: 10.1158/1078-0432.ccr-07-4717]
84. Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL, Zona GL, Spaziante R, Florio T, Schettini G. Stromal cellderived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signalregulated kinases 1/2 and Akt. Cancer Res 2003; 63: 1969-1974 [PMID: 12702590]
85. Bajetto A, Barbieri F, Dorcaratto A, Barbero S, Daga A, Porcile C, Ravetti JL, Zona G, Spaziante R, Corte G, Schettini G, Florio T. Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration. Neurochem Int 2006; 49: 423-432 [PMID: 16621164 DOI: 10.1016/ j.neuint.2006.03.003]
86. Lee HJ, Lee K, Lee DG, Bae KH, Kim JS, Liang ZL, Huang SM, Suk Oh Y, Kim HY, Jo DY, Min JK, Kim JM, Lee HJ. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor. Clin Cancer Res 2012; 18: 3270-3280 [PMID: 22553346 DOI: 10.1158/1078-0432.ccr-11-2417]
87. Zhuang Y, Peng LS, Zhao YL, Shi Y, Mao XH, Chen W, Pang KC, Liu XF, Liu T, Zhang JY, Zeng H, Liu KY, Guo G, Tong WD, Shi Y, Tang B, Li N, Yu S, Luo P, Zhang WJ, Lu DS, Yu PW, Zou QM. CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer. Gastroenterology 2012; 143: 951-962. e8 [PMID: 22710190 DOI: 10.1053/ j.gastro.2012.06.010]
88. Shibata W, Ariyama H, Westphalen CB, Worthley DL, Muthupalani S, Asfaha S, Dubeykovskaya Z, Quante M, Fox JG, Wang TC. Stromal cell-derived factor-1 overexpression induces gastric dysplasia through expansion of stromal myofibroblasts and epithelial progenitors. Gut 2013; 62: 192-200 [PMID: 22362916 DOI: 10.1136/gutjnl-2011-301824]
89. Oh YS, Kim HY, Song IC, Yun HJ, Jo DY, Kim S, Lee HJ. Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α. Oncol Rep 2012; 28: 2239-2246 [PMID: 23023480 DOI: 10.3892/or.2012.2063]
90. Fernandis AZ, Prasad A, Band H, Klösel R, Ganju RK. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 2004; 23: 157-167 [PMID: 14712221. DOI: 10.1038/sj.onc.1206910]
91. Hartmann TN, Burger JA, Glodek A, Fujii N, Burger M. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene 2005; 24: 4462-4471 [PMID: 15806155. DOI: 10.1038/sj.onc.1208621]
92. Luker KE, Luker GD. Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett 2006; 238: 30-41 [PMID: 16046252 DOI: 10.1016/j.canlet.2005.06.021]
93. Yamashita K, Azumano I, Mai M, Okada Y. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis. Int J Cancer 1998; 79: 187-194 [PMID: 9583735]
94. Shim KN, Jung SA, Joo YH, Yoo K. Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer. J Gastroenterol 2007; 42: 120-128 [PMID: 17351800 DOI: 10.1007/s00535-006-1975-y]
95. Dubeykovskaya Z, Dubeykovskiy A, Solal-Cohen J, Wang TC. Secreted trefoil factor 2 activates the CXCR4 receptor in epithelial and lymphocytic cancer cell lines. J Biol Chem 2009; 284: 3650-3662 [PMID: 19064997 DOI: 10.1074/jbc. M804935200]
96. Koizumi K, Kato S, Sakurai H, Hashimoto I, Yasumoto K, Saiki I. Therapeutics target of CXCR4 and its downstream in peritoneal carcinomatosis of gastric cancer. Front Biosci (Schol Ed) 2012; 4: 269-276 [PMID: 22202059]
97. Soriano SF, Serrano A, Hernanz-Falcón P, Martín de Ana A, Monterrubio M, Martínez C, Rodríguez-Frade JM, Mellado M. Chemokines integrate JAK/STAT and G-protein pathways during chemotaxis and calcium flux responses. Eur J Immunol 2003; 33: 1328-1333 [PMID: 12731058 DOI: 10.1002/ eji.200323897]
98. Maksym RB, Tarnowski M, Grymula K, Tarnowska J, Wysoczynski M, Liu R, Czerny B, Ratajczak J, Kucia M, Ratajczak MZ. The role of stromal-derived factor-1--CXCR7 axis in development and cancer. Eur J Pharmacol 2009; 625: 31-40 [PMID: 19835865 DOI: 10.1016/j.ejphar.2009.04.071]
99. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, Kuo CJ, Wei K, McMaster BE, Wright K, Howard MC, Schall TJ. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 2006; 203: 2201-2213 [PMID: 16940167 DOI: 10.1084/ jem.20052144]
100. Miao Z, Luker KE, Summers BC, Berahovich R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A, Luker GD, Howard MC, Schall TJ. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 2007; 104: 15735-15740 [PMID: 17898181 DOI: 10.1073/ pnas.0610444104]
101. Lee HJ, Lee KS, Ryu H, Song IC, Huang SM, Yun HJ, Kim J, Jo DY, Kim S. The combined expression of CXCR7 and its ligand CXCL12 is a marker for unfavorable prognosis in gastric cancer. Ann Oncol 2012; 23 suppl 9: 541-541 Available from: URL: http://annonc.oxfordjournals.org/content/ 23/suppl_9/ix541.full?sid=956a7a70-63a0-4e96-80d1-7d8982754c6c
102. Miyazaki H, Takabe K, Yeudall WA. Chemokines, chemokine receptors and the gastrointestinal system. World J Gastroenterol 2013; 19: 2847-2863 [PMID: 23704819 DOI: 10.3748/ wjg.v19.i19.2847]
103. Sieveking D, Mitchell HM, Day AS. Gastric epithelial cell CXC chemokine secretion following Helicobacter pylori infection in vitro. J Gastroenterol Hepatol 2004; 19: 982-987 [PMID: 15304113 DOI: 10.1111/j.1440-1746.2004.03413.x]
104. Kitadai Y, Haruma K, Sumii K, Yamamoto S, Ue T, Yokozaki H, Yasui W, Ohmoto Y, Kajiyama G, Fidler IJ, Tahara E. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 1998; 152: 93-100 [PMID: 9422527]
105. Torti D, Sassi F, Galimi F, Gastaldi S, Perera T, Comoglio PM, Trusolino L, Bertotti A. A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors. Int J Cancer 2012; 130: 1357-1366 [PMID: 21500189 DOI: 10.1002/ ijc.26137]
106. Kido S, Kitadai Y, Hattori N, Haruma K, Kido T, Ohta M, Tanaka S, Yoshihara M, Sumii K, Ohmoto Y, Chayama K. Interleukin 8 and vascular endothelial growth factor--prognostic factors in human gastric carcinomas? Eur J Cancer 2001; 37: 1482-1487 [PMID: 11506954]
107. Ju DW, Wei PK, Lin HM, Sun DZ, Yu S, Xiu LJ. Effects of Xiaotan Sanjie Decoction on expressions of interleukin-8 and its receptors in gastric tumor xenografts and gastric tissue adjacent to the tumor in mice. Zhongxi Yijiehe Xuebao 2010; 8: 74-79 [PMID: 20082763]
108. Sakitani K, Hirata Y, Hayakawa Y, Serizawa T, Nakata W, Takahashi R, Kinoshita H, Sakamoto K, Nakagawa H, Akanuma M, Yoshida H, Maeda S, Koike K. Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation. Infect Immun 2012; 80: 3795-3803 [PMID: 22890997 DOI: 10.1128/iai.00637-12]
109. Eck M, Schmausser B, Scheller K, Brändlein S, Müller-Hermelink HK. Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma. Clin Exp Immunol 2003; 134: 508-515 [PMID: 14632759]
110. Allison CC, Ferrand J, McLeod L, Hassan M, Kaparakis-Liaskos M, Grubman A, Bhathal PS, Dev A, Sievert W, Jenkins BJ, Ferrero RL. Nucleotide oligomerization domain 1 enhances IFN-γ signaling in gastric epithelial cells during Helicobacter pylori infection and exacerbates disease severity. J Immunol 2013; 190: 3706-3715 [PMID: 23460743 DOI: 10.4049/jimmunol.1200591]
111. Macrì A, Versaci A, Loddo S, Scuderi G, Travagliante M, Trimarchi G, Teti D, Famulari C. Serum levels of interleukin 1beta, interleukin 8 and tumour necrosis factor alpha as markers of gastric cancer. Biomarkers 2006; 11: 184-193 [PMID: 16766394. DOI: 10.1080/13547500600565677]
112. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA, Strieter RM. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 1994; 179: 1409-1415 [PMID: 7513008]
113. Yoneda J, Kuniyasu H, Crispens MA, Price JE, Bucana CD, Fidler IJ. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J Natl Cancer Inst 1998; 90: 447-454 [PMID: 9521169]
114. Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res 2000; 6: 2104-2119 [PMID: 10815938]
115. Kitadai Y, Takahashi Y, Haruma K, Naka K, Sumii K, Yokozaki H, Yasui W, Mukaida N, Ohmoto Y, Kajiyama G, Fidler IJ, Tahara E. Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer 1999; 81: 647-653 [PMID: 10574250 DOI: 10.1038/sj.bjc.6690742]
116. Ju D, Sun D, Xiu L, Meng X, Zhang C, Wei P. Interleukin-8 is associated with adhesion, migration and invasion in human gastric cancer SCG-7901 cells. Med Oncol 2012; 29: 91-99 [PMID: 21191670 DOI: 10.1007/s12032-010-9780-0]
117. Kuai WX, Wang Q, Yang XZ, Zhao Y, Yu R, Tang XJ. Interleukin-8 associates with adhesion, migration, invasion and chemosensitivity of human gastric cancer cells. World J Gastroenterol 2012; 18: 979-985 [PMID: 22408359 DOI: 10.3748/ wjg.v18.i9.979]
118. Taguchi A, Ohmiya N, Shirai K, Mabuchi N, Itoh A, Hirooka Y, Niwa Y, Goto H. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 2005; 14: 2487-2493 [PMID: 16284368 DOI: 10.1158/1055-9965.epi-05-0326]
119. Ye BD, Kim SG, Park JH, Kim JS, Jung HC, Song IS. The interleukin-8-251 A allele is associated with increased risk of noncardia gastric adenocarcinoma in Helicobacter pyloriinfected Koreans. J Clin Gastroenterol 2009; 43: 233-239 [PMID: 18542040. DOI: 10.1097/MCG.0b013e3181646701]
120. Ohyauchi M, Imatani A, Yonechi M, Asano N, Miura A, Iijima K, Koike T, Sekine H, Ohara S, Shimosegawa T. The polymorphism interleukin 8-251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 2005; 54: 330-335 [PMID: 15710978 DOI: 10.1136/gut.2003.033050]
121. Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 2005; 26: 631-636 [PMID: 15579481. DOI: 10.1093/carcin/bgh349]
122. Wang J, Pan HF, Hu YT, Zhu Y, He Q. Polymorphism of IL-8 in 251 allele and gastric cancer susceptibility: a metaanalysis. Dig Dis Sci 2010; 55: 1818-1823 [PMID: 19777350 DOI: 10.1007/s10620-009-0978-y]
123. Vinagre RM, Corvelo TC, Arnaud VC, Leite AC, Barile KA, Martins LC. Determination of strains of Helicobacter pylori and of polymorphism in the interleukin-8 gene in patients with stomach cancer. Arq Gastroenterol 2011; 48: 46-51 [PMID: 21537542]
124. Song JH, Kim SG, Jung SA, Lee MK, Jung HC, Song IS. The interleukin-8-251 AA genotype is associated with angiogenesis in gastric carcinogenesis in Helicobacter pylori-infected Koreans. Cytokine 2010; 51: 158-165 [PMID: 20621718 DOI: 10.1016/j.cyto.2010.05.001]
125. Wang JP, Hu WM, Wang KS, Luo BH, Wu C, Chen ZH, Luo GQ, Liu YW, Liu QL, Yu J, Li JH, Wen JF. Upregulation of C-X-C chemokine receptor type 1 expression is associated with late-stage gastric adenocarcinoma. Exp Ther Med 2012; 4: 55-60 [PMID: 23060922 DOI: 10.3892/etm.2012.568]
126. Wang JP, Hu WM, Wang KS, Yu J, Luo BH, Wu C, Chen ZH, Luo GQ, Liu YW, Liu QL, Xiao Y, Zhou HY, Yang XJ, Jiang HY, Li JH, Wen JF. Expression of C-X-C chemokine receptor types 1/2 in patients with gastric carcinoma: Clinicopathological correlations and significance. Oncol Lett 2013; 5: 574-582 [PMID: 23420470 DOI: 10.3892/ol.2012.1043]
127. Kitadai Y, Haruma K, Mukaida N, Ohmoto Y, Matsutani N, Yasui W, Yamamoto S, Sumii K, Kajiyama G, Fidler IJ, Tahara E. Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8. Clin Cancer Res 2000; 6: 2735-2740 [PMID: 10914718]
128. Ewington L, Taylor A, Sriraksa R, Horimoto Y, Lam EW, El-Bahrawy MA. The expression of interleukin-8 and interleukin-8 receptors in endometrial carcinoma. Cytokine 2012; 59: 417-422 [PMID: 22626766 DOI: 10.1016/j.cyto.2012.04.036]
129. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008; 14: 6735-6741 [PMID: 18980965 DOI: 10.1158/1078-0432.ccr-07-4843]
130. Junnila S, Kokkola A, Mizuguchi T, Hirata K, Karjalainen-Lindsberg ML, Puolakkainen P, Monni O. Gene expression analysis identifies over-expression of CXCL1, SPARC, SPP1, and SULF1 in gastric cancer. Genes Chromosomes Cancer 2010; 49: 28-39 [PMID: 19780053 DOI: 10.1002/gcc.20715]
131. Cheng WL, Wang CS, Huang YH, Tsai MM, Liang Y, Lin KH. Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer. Ann Oncol 2011; 22: 2267-2276 [PMID: 21343381 DOI: 10.1093/annonc/mdq739]
132. Xu J, Zhang C, He Y, Wu H, Wang Z, Song W, Li W, He W, Cai S, Zhan W. Lymphatic endothelial cell-secreted CXCL1 stimulates lymphangiogenesis and metastasis of gastric cancer. Int J Cancer 2012; 130: 787-797 [PMID: 21387301 DOI: 10.1002/ijc.26035]
133. Kuzuhara T, Suganuma M, Kurusu M, Fujiki H. Helicobacter pylori-secreting protein Tipalpha is a potent inducer of chemokine gene expressions in stomach cancer cells. J Cancer Res Clin Oncol 2007; 133: 287-296 [PMID: 17393199 DOI: 10.1007/s00432-006-0169-6]
134. Karasawa F, Shiota A, Goso Y, Kobayashi M, Sato Y, Masumoto J, Fujiwara M, Yokosawa S, Muraki T, Miyagawa S, Ueda M, Fukuda MN, Fukuda M, Ishihara K, Nakayama J. Essential role of gastric gland mucin in preventing gastric cancer in mice. J Clin Invest 2012; 122: 923-934 [PMID: 22307328. DOI: 10.1172/jci59087]
135. Sheh A, Ge Z, Parry NM, Muthupalani S, Rager JE, Raczynski AR, Mobley MW, McCabe AF, Fry RC, Wang TC, Fox JG. 17β-estradiol and tamoxifen prevent gastric cancer by modulating leukocyte recruitment and oncogenic pathways in Helicobacter pylori-infected INS-GAS male mice. Cancer Prev Res (Phila) 2011; 4: 1426-1435 [PMID: 21680705 DOI: 10.1158/1940-6207.capr-11-0219]
136. Tang W, Morgan DR, Meyers MO, Dominguez RL, Martinez E, Kakudo K, Kuan PF, Banet N, Muallem H, Woodward K, Speck O, Gulley ML. Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile. Infect Agent Cancer 2012; 7: 21 [PMID: 22929309 DOI: 10.1186/1750-9378-7-21]
137. Jung JJ, Noh S, Jeung HC, Jung M, Kim TS, Noh SH, Roh JK, Chung HC, Rha SY. Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progression. Cancer Sci 2010; 101: 2200-2206 [PMID: 20731665 DOI: 10.1111/ j.1349-7006.2010.01666.x]
138. Sharma B, Nawandar DM, Nannuru KC, Varney ML, Singh RK. Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis. Mol Cancer Ther 2013; 12: 799-808 [PMID: 23468530. DOI: 10.1158/1535-7163.mct-12-0529]
139. Yamamoto M, Kikuchi H, Ohta M, Kawabata T, Hiramatsu Y, Kondo K, Baba M, Kamiya K, Tanaka T, Kitagawa M, Konno H. TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche. Cancer Res 2008; 68: 9754-9762 [PMID: 19047154 DOI: 10.1158/0008-5472. can-08-1748]
140. Singh S, Sadanandam A, Nannuru KC, Varney ML, Mayer-Ezell R, Bond R, Singh RK. Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis. Clin Cancer Res 2009; 15: 2380-2386 [PMID: 19293256 DOI: 10.1158/1078-0432.ccr-08-2387]
141. Okayama H, Kumamoto K, Saitou K, Hayase S, Kofunato Y, Sato Y, Miyamoto K, Nakamura I, Ohki S, Sekikawa K, Takenoshita S. CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer. Oncol Rep 2009; 22: 745-755 [PMID: 19724852]
142. Park JY, Park KH, Bang S, Kim MH, Lee JE, Gang J, Koh SS, Song SY. CXCL5 overexpression is associated with late stage gastric cancer. J Cancer Res Clin Oncol 2007; 133: 835-840 [PMID: 17479287 DOI: 10.1007/s00432-007-0225-x]
143. Kraft M, Riedel S, Maaser C, Kucharzik T, Steinbuechel A, Domschke W, Luegering N. IFN-gamma synergizes with TNF-alpha but not with viable H. pylori in up-regulating CXC chemokine secretion in gastric epithelial cells. Clin Exp Immunol 2001; 126: 474-481 [PMID: 11737065]
144. Rajkumar T, Vijayalakshmi N, Gopal G, Sabitha K, Shirley S, Raja UM, Ramakrishnan SA. Identification and validation of genes involved in gastric tumorigenesis. Cancer Cell Int 2010; 10: 45 [PMID: 21092330 DOI: 10.1186/1475-2867-10-45]
145. Ohtani H, Jin Z, Takegawa S, Nakayama T, Yoshie O. Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma. J Pathol 2009; 217: 21-31 [PMID: 18980207 DOI: 10.1002/path.2448]
146. Deng L, Chen N, Li Y, Zheng H, Lei Q. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer. Biochim Biophys Acta 2010; 1806: 42-49 [PMID: 20122997 DOI: 10.1016/j.bbcan.2010.01.004]
147. Darash-Yahana M, Gillespie JW, Hewitt SM, Chen YY, Maeda S, Stein I, Singh SP, Bedolla RB, Peled A, Troyer DA, Pikarsky E, Karin M, Farber JM. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers. PLoS One 2009; 4: e6695 [PMID: 19690611. DOI: 10.1371/journal.pone.0006695]
148. Hojo S, Koizumi K, Tsuneyama K, Arita Y, Cui Z, Shinohara K, Minami T, Hashimoto I, Nakayama T, Sakurai H, Takano Y, Yoshie O, Tsukada K, Saiki I. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer. Cancer Res 2007; 67: 4725-4731 [PMID: 17510400. DOI: 10.1158/0008-5472.can-06-3424]
149. Xing YN, Xu XY, Nie XC, Yang X, Yu M, Xu HM, Liu YP, Takano Y, Zheng HC. Role and clinicopathologic significance of CXC chemokine ligand 16 and chemokine (C-X-C motif) receptor 6 expression in gastric carcinomas. Hum Pathol 2012; 43: 2299-2307 [PMID: 22863086 DOI: 10.1016/ j.humpath.2011.08.027]
150. Duda DG, Kozin SV, Kirkpatrick ND, Xu L, Fukumura D, Jain RK. CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies? Clin Cancer Res 2011; 17: 2074-2080 [PMID: 21349998 DOI: 10.1158/1078-0432.ccr-10-2636]
151. Iwanaga T, Iwasaki Y, Ohashi M, Nunobe S, Iwagami S. [Establishment of a CXCR4-expressing gastric cancer cell line in nude mice and the effect of AMD 3100 on tumor regression]. Gan To Kagaku Ryoho 2007; 34: 1917-1919 [PMID: 18219852]
152. Iwanaga T, Iwasaki Y, Ohashi M, Ohinata R, Takahashi K, Yamaguchi T, Matsumoto H, Nakano D. [Inhibitory effect of CXCR4 blockers on a CXCR4-expressing gastric cancer cell line in nude mice]. Gan To Kagaku Ryoho 2012; 39: 1788-1790 [PMID: 23267887]
153. Xie L, Wei J, Qian X, Chen G, Yu L, Ding Y, Liu B. CXCR4, a potential predictive marker for docetaxel sensitivity in gastric cancer. Anticancer Res 2010; 30: 2209-2216 [PMID: 20651371]
154. Manu KA, Shanmugam MK, Rajendran P, Li F, Ramachandran L, Hay HS, Kannaiyan R, Swamy SN, Vali S, Kapoor S, Ramesh B, Bist P, Koay ES, Lim LH, Ahn KS, Kumar AP, Sethi G. Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4. Mol Cancer 2011; 10: 107 [PMID: 21880153. DOI: 10.1186/1476-4598-10-107]
155. Ning Y, Labonte MJ, Zhang W, Bohanes PO, Gerger A, Yang D, Benhaim L, Paez D, Rosenberg DO, Nagulapalli Venkata KC, Louie SG, Petasis NA, Ladner RD, Lenz HJ. The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models. Mol Cancer Ther 2012; 11: 1353-1364 [PMID: 22391039 DOI: 10.1158/1535-7163.mct-11-0915]
156. Varney ML, Li A, Dave BJ, Bucana CD, Johansson SL, Singh RK. Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype. Clin Exp Metastasis 2003; 20: 723-731 [PMID: 14713106]
157. Singh JK, Farnie G, Bundred NJ, Simões BM, Shergill A, Landberg G, Howell SJ, Clarke RB. Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and-independent mechanisms. Clin Cancer Res 2013; 19: 643-656 [PMID: 23149820 DOI: 10.1158/1078-0432. ccr-12-1063]
158. Mian BM, Dinney CP, Bermejo CE, Sweeney P, Tellez C, Yang XD, Gudas JM, McConkey DJ, Bar-Eli M. Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB. Clin Cancer Res 2003; 9: 3167-3175 [PMID: 12912969]
159. Singh S, Sadanandam A, Varney ML, Nannuru KC, Singh RK. Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion. Int J Cancer 2010; 126: 328-336 [PMID: 19585580 DOI: 10.1002/ijc.24714]
160. Varney ML, Singh S, Li A, Mayer-Ezell R, Bond R, Singh RK. Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases. Cancer Lett 2011; 300: 180-188 [PMID: 21035946 DOI: 10.1016/j.canlet.2010.10.004]